Skift

Hilton faces escalating activist pressure over ICE housing, American Airlines flight attendants issue a no-confidence vote in CEO Robert Isom, and GLP-1 drugs like Ozempic begin reshaping how travelers spend on food, alcohol, and wellness. On today’s Skift Daily Briefing, Sarah Dandashy⁠ unpacks how reputational risk is turning personal for hotel brands, why labor tensions at American signal deeper operational strain, and how weight-loss drugs are quietly reallocating travel dollars. This episode is presented by ⁠⁠⁠⁠Lodgify!⁠⁠⁠⁠ Articles Referenced: Honorable Mention: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@AskAConcierge on IG⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ American Airlines FlightAttendants Issue No-Confidence Vote in CEO Robert Isom America’s Vacation Was Built on Gluttony. Ozempic Killed the Buzz Activists Target Hilton CEO’s Home Over ICE Housing Connect with Skift LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/compan